首页 | 本学科首页   官方微博 | 高级检索  
   检索      

氨溴索与肝素联合应用对急性肺损伤兔TNF-α和IL-1β的影响
引用本文:汪洋,王方岩,潘湛,戴雍月,徐和靖,金可可,王万铁.氨溴索与肝素联合应用对急性肺损伤兔TNF-α和IL-1β的影响[J].中国应用生理学杂志,2011(2):231-235,259.
作者姓名:汪洋  王方岩  潘湛  戴雍月  徐和靖  金可可  王万铁
作者单位:温州医学院病理生理学教研室;温州医学院生理教研室;
基金项目:温州市科技局科研基金资助项目(Hxo7012)
摘    要:目的:探讨联合应用氨溴索与小剂量肝素对急性肺损伤(ALI)时氧化应激,TNF-α和IL-1β变化的干预及其机制。方法:健康日本大耳白兔24只,随机分成3组(n=8):①生理盐水对照组(NC),②油酸损伤组(OA),③氨溴索+小剂量肝素治疗组(AH)。各组分别在给药前和给药后6 h采血及测定动脉血氧分压(PaO2)、肿瘤坏死因子-α(TNF-α)、白介素-1β(IL-1β)的含量,实验结束后肉眼观察肺病理改变,测定支气管肺泡灌洗液(BALF)以及肺组织匀浆中TNF-α、IL-1β、超氧化物歧化酶(SOD)、丙二醛(MDA)、黄嘌呤氧化酶(XO)、谷胱甘肽过氧化物酶(GSH-Px)的含量,检测肺组织原位凋亡细胞变化、肺组织湿干比(W/D),光镜观察肺组织病理改变,电镜观察肺组织超微结构变化。结果:①光镜,电镜观察结果以及W/D提示氨溴索+小剂量联合治疗减轻了ALI造成的肺组织形态学改变。②OA组中显著降低的PaO2均在AH组明显升高(P〈0.01)。③抗氧化指标GSH-Px和SOD活力检测,发现AH组比OA组有不同程度升高(P〈0.01或P〈0.05),而氧化性指标XO活力和MDA含量则较OA组显著降低(P〈0.01)。④除给药前IL-1β外,在OA组中IL-1β、TNF-α含量均显著高于NC组(P均〈0.01),但在AH组中有显著的降低(P〈0.01)。⑤AH组凋亡指数(AI)比OA组显著降低(P〈0.01)。结论:在OA致ALI时,TNF-α和IL-1β明显升高,参与了ALI的发生与发展。联合应用氨溴索与小剂量肝素可减轻氧化应激反应,抑制促炎细胞因子TNF-α和IL-1β释放,发挥对ALI的治疗作用。

关 键 词:急性肺损伤  氨溴索  肝素  细胞因子  IL-1β  TNF-α  氧化应激  细胞凋亡

Effects of ambroxol combined with low-dose heparin on TNF-α and IL-1β in rabbits with acute lung injury
WANG Yang,WANG Fang-yan,PAN Zhan,DAI Yong-yue,XU He-jing,JIN Ke-ke,WANG Wan-tie.Effects of ambroxol combined with low-dose heparin on TNF-α and IL-1β in rabbits with acute lung injury[J].Chinese Journal of Applied Physiology,2011(2):231-235,259.
Authors:WANG Yang  WANG Fang-yan  PAN Zhan  DAI Yong-yue  XU He-jing  JIN Ke-ke  WANG Wan-tie
Institution:WANG Yang1,WANG Fang-yan1,PAN Zhan1,DAI Yong-yue1,XU He-jing2,JIN Ke-ke1,WANG Wan-tie1(1.Department of Pathophysiology,2.Department of Physiology,Wenzhou Medical college,Wenzhou 325035,China)
Abstract:Objective:To investigate the intervention and mechanism of ambroxol combined with low-dose heparin on oxidative stress,TNF-α and IL-1β in rabbits with acute lung injury(ALI).Methods:Twenty-four healthy Japanese rabbits were randomly divided into three groups:①Normal saline control group(NC),②Oleic acid injury group(OA),③Ambroxol+low-dose heparin therapy group(AH). After the success of ALI model,AH group was injected ambroxol+low-dose heparin,while the NC group and OA group were injected the same dose of normal saline by the same method.Arterial oxygen tension(PaO2),tumor necrosis factor-α(TNF-α) and interleukin-1β(IL-1β) at different time points were determined.The pathological manifestation of both side lungs was observed at the end of expeiment.The activity of glutathione peroxidase(GSH-Px),superoxide dismutase(SOD),xanthine oxidase(XO) and the content of malondialdehyde(MDA) in bronchoalveolar lavage fluid(BALF) and lung tissue homogenate were tested.The apoptosis index was detected.The lung wet/dry(W/D) ratio was calculated.The pathological changes in lung tissue were observed by light microscopy,and the ultrastructural changes of lung tissue were observed by electron microscopy.Results:①The instructive injury induced by ALI observed under electron microscope and light microscope and W/D was decreased significantly in AH group.②PaO2 was improved significantly in AH group,compared with that in OA group(P0.01).③The activity of GSH-Px and SOD in AH group increased significantly(P0.01 or P0.05) but the activity of XO and the content of MDA decreased significantly(P0.01),compared with those in OA group.④Except the content of IL-1β in serum before treatment,the content of IL-1β and TNF-α in serum,BALF,lung tissue homogenate of OA group increased significantly(P0.01),and those were obviously improved in AH group.⑤Apoptosis index(AI) in AH group decreased significantly(P0.01) compared with that in OA group.Conclusion:In ALI induced by OA,IL-1β and TNF-α increases significantly and involved in the occurrence and development of ALI.Ambroxol combined with low-dose heparin can reduce lung cells oxidative stress to inhibit the release of IL-1β and TNF-α,which play a role in the treatment of ALI.
Keywords:acute lung injury  ambroxol  heparin  cytokine  IL-1β  TNF-α  oxidative stress  apoptosis
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号